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Metagenomic identification 
of a new sarbecovirus 
from horseshoe bats in Europe
Jack M. Crook1,5,6, Ivana Murphy2,6, Daniel P. Carter1, Steven T. Pullan1, Miles Carroll1,3, 
Richard Vipond1, Andrew A. Cunningham4,6* & Diana Bell2,6
The source of the COVID-19 pandemic is unknown, but the natural host of the progenitor sarbecovirus 
is thought to be Asian horseshoe (rhinolophid) bats. We identified and sequenced a novel sarbecovirus 
(RhGB01) from a British horseshoe bat, at the western extreme of the rhinolophid range. Our 
results extend both the geographic and species ranges of sarbecoviruses and suggest their presence 
throughout the horseshoe bat distribution. Within the spike protein receptor binding domain, 
but excluding the receptor binding motif, RhGB01 has a 77% (SARS-CoV-2) and 81% (SARS-CoV) 
amino acid homology. While apparently lacking hACE2 binding ability, and hence unlikely to be 
zoonotic without mutation, RhGB01 presents opportunity for SARS-CoV-2 and other sarbecovirus 
homologous recombination. Our findings highlight that the natural distribution of sarbecoviruses 
and opportunities for recombination through intermediate host co-infection are underestimated. 
Preventing transmission of SARS-CoV-2 to bats is critical with the current global mass vaccination 
campaign against this virus.
The sources of the current COVID-19 pandemic and of the 2003 Severe Acute Respiratory Syndrome (SARS) 
epidemic are  unknown1. Currently, the natural hosts of both SARS-CoV and SARS-CoV-2 (family Coronaviridae; 
subgenus Sarbecovirus)2, the causative agents of SARS and COVID-19 respectively, are thought to be horseshoe 
bats (Rhinolophidae), with the zoonotic spillover process involving one or more intermediate hosts, during 
which time viral mutation, recombination and/or amplification could have  occurred3–7. Phylogenetic analyses 
of novel horseshoe bat sarbecoviruses in China have shown these to be most closely related to both SARS-CoV 
and to SARS-CoV-23,4,7. Recently, a SARS-CoV-2-like virus was also reported from a species of horseshoe bat 
in  Thailand8.
The range of horseshoe bats extends across much of the Old World, but most sampling for coronaviruses 
has been conducted in East and South East Asia, where around 50 SARS-related coronaviruses (SARSr-CoVs) 
have been detected across ten species of bat, with 48 of these being from nine species of horseshoe  bat8–11. Here 
we expand the investigation of SARSr-CoVs to the lesser horseshoe bat (Rhinolophus hipposideros) in the UK, 
which is at the western extreme of the range of the Rhinolophidae.
Methods
Sample collection. Faecal samples were collected from lesser horseshoe bats R. hipposideros during routine 
annual population monitoring surveys at three sites in August and September 2020 following approval by the 
University of East Anglia Ethics Committee and adhering to UK Government COVID-19 safety regulations in 
place at the time. Samples were either obtained from individual bats at the time of capture or from under-roost 
sampling. In Somerset (n = 20 bats) and Monmouthshire, Wales (n = 7) bats were captured using harp traps or 
mist nets placed near roosts or in woodland under government license. A faecal pellet was collected from each 
of 23 bats held individually in sterile holding bags and the other four samples were collected as anal swabs using 
rayon-tipped dry swabs (MW100; Medical Wire & Equipment), which were taken from bats that did not defae-
cate when captured. All bats were released at the site of capture immediately after sample collection. In Glouces-
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tershire, 26 faecal pellets were collected by placing a sterile sheet underneath a lesser horseshoe roost and any 
droppings that landed directly onto the sheet within 30 min were collected. Each faecal sample was placed into 
an individual sterile tube containing 2 ml RNAlater, refrigerated overnight and stored frozen prior to analysis.
Genomic sequencing. For metagenomic analysis, samples were homogenised by vortexing and spiked 
with 10^6 genome copies per ml of Hazara virus as an internal control. A 140 µl aliquot of each sample was 
extracted using the QIAamp Viral RNA extraction kit. Extracts were DNase treated, reverse transcribed and ran-
domly amplified using a Sequence-Independent Single-Primer Amplification (SISPA) based method described 
in detail  previously12. Illumina sequencing used the Nextera XT protocol with 2 × 150-bp paired-end sequenc-
ing on a MiSeq. Nanopore library preparation was as described  previously12 and sequencing was performed on 
an Oxford nanopore GridION with base calling via Guppy. Nanopore reads were trimmed using  NanoFilt13 to 
remove 25 bp SISPA primer sequences from the start and end of each read. Raw data and the assembly sequence 
are deposited at NCBI under BioProject PRNJA706167.
Genomic analyses. Read-level taxonomic classification for each sample was performed using Kraken2 
against the RefSeq database (2.0.8-beta)14. De novo genome assembly was performed using SPAdes (3.15.1) for 
both Illumina and Illumina/nanopore hybrid  assemblies15. Contigs of interest were identified using  BLASTn16. 
Illumina reads were mapped to the assembled contigs of interest using BWA-MEM17 and nanopore reads using 
 Minimap218. Read depth values were generated using SAMtools (1.10)19.
The assembled genome was aligned with selected reference genomes (NC_014470.1, KJ473814.1, 
NC_045512.2) in MEGA X (10.2.4) using MUSCLE  alignment20,21. Nucleotide and codon alignments were gen-
erated for each gene with visual depictions of alignment and pairwise alignment scores generated in JALVIEW 
(2.11.1.3)22.
Aligned nucleotide sequences from 21 sarbecoviruses obtained from GenBank were used to generate maxi-
mum likelihood trees using IQTREE (2.0.3)23. The best fitting nucleotide substitution model was used as selected 
by ModelFinder for each individual  phylogeny24. Nodes were evaluated using UFBoot with 1,000 bootstrap 
 approximations25. Phylogenetic tree visualisation was carried out in FigTree (5.7)26.
Homology modelling. SWISS-MODEL was used for homology modelling of the tertiary structure of the 
receptor binding domain (RBD) in  RhGB0127. The input target sequence was residues 324–515 in the spike 
protein sequence. SWISS-MODEL performs a template search of BLAST and HHblits databases for pre-exist-
ing characterised structures with homology. The most suitable template was selected according to the highest 
Global Model Quality Estimate (GMQE) and lowest Quaternary Structure Quality Estimate (QMEAN). GMQE 
expresses the accuracy of the model built as a number between 0 and 1. QMEAN uses statistical potentials 
of mean force to generate global and per residue estimates. Modelling of the complete S protein amino acid 
sequence did not yield reliable models (GMQE < 0.65), whereas modelling of the RBD amino acid sequence 
yielded a reliable model (GMQE > 0.7, QMEAN − 2.18). The template structure selected was the crystal structure 
of SARS-CoV RBD complexed with a neutralising antibody (PDB ID 2DD8).
The predicted 3D structure was visualised in Visual Molecular  Dynamics28 using sequence alignment and 
STAMP structural alignments for superimpositions. Structural identity is represented by a Qres (Q) score where 
Q is measure of structural similarity measuring the fraction of Cα atoms that superimpose. Validation of the 
homology model was performed using  ProCheck29,30 and  ERRAT231 on the structural analysis and verification 
server (SAVES). ProCheck generates a Ramachandran plot which classifies the torsion angles of each residue in 
the predicted 3D structure into 3 groups to assess its validity. ERRAT2 uses a database of 96 high-resolution pro-
tein structures to classify the 6 types of atomic interactions (carbon–carbon, carbon–nitrogen, carbon–oxygen, 
nitrogen-nitrogen, nitrogen–oxygen, oxygen–oxygen) into correct or incorrectly determined protein regions 
based on the atomic interactions. This provides an overall quality factor for non-bonded atomic interactions 
expressed as the percentage of a protein for which the calculated values sits below the set rejection limits, with 
a score > 50 indicating a high-quality  model31.
Results
Metagenomic analysis revealed an unclassified betacoronavirus in a single sample with 
genome organisation consistent with Sarbecovirus. An initial screening of the 53 samples identified 
one sample from Gloucestershire with > 650 reads classified to the Coronavirinae family, with the positive control 
spike of Hazara virus detected in 49/53 samples. The percentage of reads classified in total in each sample ranged 
from 28 to 96% and in both the extraction and library preparation negative controls, no other significant level 
of reads classified to RNA viruses. Hazara virus was detected in the extraction negative, but not in the library 
preparation negative.
Classification of the reads in the positive sample identified 0.41% of reads (2550/614,996) as being viral in 
origin. Of these viral reads, 68% of reads (1668) were classified at species level to bat betacoronavirus BM48-31/
BGR/2008 (GenBank reference NC_014470.1)32. De novo assembly of the Illumina reads generated multiple 
contigs with homology to members of the subgenus Sarbecovirus as assessed via BLASTn; the largest single 
contig being ~ 7 kb. To investigate, further additional sequence data were generated using Oxford nanopore 
technology. Using the 562,461 nanopore reads with an average length of ~ 600 kb as scaffold, a hybrid assembly 
generated a single 29 kb contig similar to sarbecovirus genomes in both size and gene organisation (Fig. 1A,B). 
To increase confidence in the assembly we performed further Illumina sequencing. With the increased depth, 
Illumina data alone were assembled into a contig of 21 kb, which was again further assembled to a 29 kb contig 
with the inclusion of the nanopore data in a hybrid assembly. Mapping all raw reads to this contig shows that 
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0.97% and 2.37% map to the contig for Illumina and Nanopore respectively. In total, mean read depth along the 
assembly is ~ 25 × for Illumina data and 20 × for nanopore data. Combined depth coverage across the assembly 
is ~ 50 ×, confidently supporting the presence of this virus, in the positive sample (Fig. 1C).
BLASTn analysis of the GenBank nr/nt database shows the assembly shares the highest nucleotide identity 
with a bat betacoronavirus, BtRs-betaCoV/Hub2013 (KJ473814.1), with 81.01% identity across 85% of the assem-
bly. By comparison it shares 79.78% nucleotide identity across 85% of the assembly with SARS-CoV-2 (isolate 
SARS-CoV-2/human/USA/FL-CDC-STM-000005640/2021, MW586221.1). We named the virus identified as 
RhGB01 (Rhinolophus hipposideros, Great Britain 01) representing the first detection of a sarbecovirus from R. 
hipposideros in Great Britain.
The genomic structure of RhGB01 mostly mirrors that of other sarbecoviruses with genes encoding non-
structural proteins (nsp) in the 5′ region of the genome housed within ORF1ab, and genes encoding structural 
and accessory proteins at the 3′ region of the genome (Fig. 1A,B)33. RhGB01 contains 10 coding genes, whereas 
SARS-CoV-2, SARS and SARSr-CoV-2 viruses contain 11 coding genes, with the addition of ORF8. In RhGB01, 
ORF8 and 20 bases in the 5′ region of the ORF7b transcript are absent, comparable to BM48-31/BGR/2008, the 
closest related virus as determined by phylogenetic analysis (Fig. 2; Supplementary Fig. 1).
Phylogenetic analysis. Maximum likelihood phylogenies of the spike glycoprotein and RdRp (nsp12) 
nucleotide sequences demonstrate that RhGB01 clusters in a monophyletic clade with BM48-31/BGR/2008, a 
sarbecovirus isolated from a Blasius’s horseshoe bat (Rhinolophus blasii) in 2008 in Bulgaria (Fig. 2). This cluster-
ing is maintained within phylogenies inferred from nucleotide sequences for all structural and accessory pro-
teins (Supplementary Fig. 1a) and most non-structural proteins (Supplementary Fig. 1b). Phylogenies inferred 
from the 3C-like proteinase, nsp9, helicase and endoRNAse nucleotide sequences demonstrate alterations in the 
clustering of RhGB01 into the SARS-CoV clade, into a clade with Rc-o139 and into its own clade, respectively 
(Supplementary Fig. 1b). In all phylogenies, RhGB01 is distinct from clades containing the human pathogenic 
betacoronaviruses SARS-CoV and SARS-CoV-2 but, of these, is more closely related to SARSr-CoVs.
The predicted structure of the receptor binding domain of RhGB01 demonstrates structural 
differences at key residues compared to SARS-CoV and SARS-CoV-2. The major human cellular 
entry receptor for both SARS-CoV and SARS-CoV-2 is Angiotensin-converting enzyme 2 (hACE2). This bind-
Figure 1.  The genomic structure of RhGB01 within the (A) entire genome, and (B) non-structural proteins. 
(C) Read depth across the genome of RhGB01. Read depth is shown per base across the entire genome from the 
alignment of Illumina (blue), Nanopore (orange) and combined raw reads (green). The lengths of the genomic 
features in RhGB01 are 5′UTR (279 bp), ORF1ab (21 kb), S (3.7 kb), ORF3a (813 bp), E (231 bp), M (669 bp), 
ORF6 (189 bp), ORF7ab (465 bp), N (1.2 kb), ORF10 (78 bp). Total genome length is 29,324 bp.
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ing ability is conferred by a receptor binding motif (RBM) within the RBD of the spike glycoprotein. RhGB01 
shares amino acid identity of 68% and 67% across the RBD with SARS-CoV and SARS-CoV-2 respectively and 
just 43% and 48% within the RBM (Fig. 3A). By comparison across the RBD, the closest SARSr-CoV-2 viruses 
from bat and pangolin hosts share 89% and 86% amino acid homology to SARS-CoV-2 and 75.77% to SARS-
CoV (Supplementary Fig. 2). Within the RBM SARSr-CoV-2 viruses from bat and pangolin hosts both share 
75% amino acid homology to SARS-CoV-2 and 50% and 49% to SARS-CoV (Fig. 3B). RhGB01 also shows little 
homology to the RBM of Middle East Respiratory Syndrome (MERS) virus (Fig. 3A). The RhGB01 spike amino 
acid sequence contains motifs comparable to host transmembrane serine protease 2 cleavage site (TMPRSS2) 
seen in both SARS-CoV-2 and SARS-CoV in the S2’ target site but lacks the additional furin cleavage site specific 
to SARS-CoV-2 at the S1/S2 intersection (Fig. 3B).
Homology modelling. The predicted 3D structure of the RBD contains one α-helix, four  310 helices, three 
β-bridges and three β-pleated sheets (Supplementary Fig. 3a). It is important to note that the majority of experi-
mentally validated spike glycoprotein and RBD structures are biased towards pathogenic viruses in complex 
with hACE2 or neutralising antibodies and the accuracy could be improved if the database included more 
zoonotic spike protein structures.
The predicted 3D structure was validated using ERRAT2 and a Ramachandran plot. The overall quality factor 
predicted by ERRAT2 is 88.09, supporting the quality of the model. The residues rejected at the 95% and 99% 
confidence levels are characterised in the literature as contact residues for SARS-CoV to hACE2, highlighting 
differences within this region compared to the SARS-CoV RBD structure (Supplementary Fig. 3b). A Ramachan-
dran plot predicted that 86% of the residues were in the most favourable region, 13.4% in additional allowed 
regions and 0.6% in generously allowed regions (Supplementary Fig. 3c).
Structural conservation within the RBD of sarbecoviruses, including RhGB01, is predicted as the RBD is 
required for viral entry into host cells via the ACE2 receptor. The predicted RBD structure of RhGB01 is more 
conserved to both SARS-CoV and SARS-CoV-2 than sequence alignment alone indicates, but still differs in 
regions containing key contact residues for binding  hACE234–42 (Fig. 4).
Discussion
Here we discovered a novel sarbecovirus (RhGB01), the first to be described in the UK, after sampling just 53 
lesser horseshoe bat faecal samples. It is possible that the infection prevalence was even higher and RT-PCR, 
which would improve sensitivity of detection, should be utilised to screen British bat samples in the future now 
a sarbecovirus has been detected in the UK. While other sarbecoviruses have been identified in rhinolophid 
bats in other European countries by polymerase chain reaction and partial gene sequence analyses, RhGB01 is 
only the second from Europe to be fully  sequenced43, and the first from a lesser horseshoe bat. The only other 
full sequence betacoronavirus from a European horseshoe bat is BM48-31/BGR/2008 from R. blasii. Our results, 
therefore, extend the geographic and species ranges of SARSr-CoVs and suggest that sarbecoviruses are likely 
Figure 2.  Maximum likelihood phylogenies of the nucleotide sequences for the (A) spike glycoprotein and (B) 
RdRp in SARS-CoV, SARS-CoV-2, and related viruses with 1000 bootstrap approximations. Each phylogeny is 
midpoint rooted and, for visualisation purposes, branch lengths (substitutions per site) in closely related clades 
and bootstrap supports ≥ 95 are removed. Green taxa are SARS-CoV-2 and related viruses, red taxa are SARS-
CoV and related viruses, blue taxa are RhGB01 and BM48-31/GBR-2008.
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to be present throughout the range of the Rhinolophidae, which are distributed from Australia and Japan to 
Europe and Africa.
The range of the lesser horseshoe bat extends from Western Europe to Central Asia, overlapping with those of 
other rhinolophid species, including the greater horseshoe bat (R. ferrumequinum), which ranges from Western 
Europe to  Japan44,45. Where they co-exist, the species can be syntopic allowing opportunity for cross-species 
virus transfer. Prior to our results, the observed and predicted (cut off ≥ 0.9821) number of coronaviruses in the 
greater horseshoe bat were 13 and 19 respectively, and in the lesser horseshoe bat these figures were zero and 
three  respectively46. This suggests that the complement of Sarbecovirus species in horseshoe bats is greater than 
predicted so far, with the possibility of virus sharing across species and large geographic areas.
Genomic alignments between RhGB01 and related sarbecoviruses highlight key genomic differences between 
RhGB01 and known zoonotic sarbecoviruses. Host specificity is dependent on the ability of a virus to attach to 
host receptors and enter host cells; a binding process facilitated by contact residues contained within the  RBM37. 
RhGB01 demonstrates low amino acid homology to SARS-CoV and SARS-CoV-2 in the RBM compared to 
that between SARS-CoV, SARS-CoV-2 and the closely related bat (RaTG13) and pangolin (PCoV_GX_P4L) 
sequences identified in  Asia48,49. The low level of homology, lack of contact residues and structural differences 
compared to the RBD of SARS-CoV and SARS-CoV-2 most likely indicate a lack of ability to bind hACE2 and, 
hence, RhGB01 is unlikely to be zoonotic without mutation. To experimentally validate the absence of hACE2 
or other human cell receptor binding and to identify binding abilities to other mammalian ACE2 receptors, 
in vitro binding assays are required.
Aside from the variation observed in amino acid homology within the RBM, RhGB01 also exhibits varia-
tion within the furin cleavage site and ORF8 when compared to zoonotic sarbecoviruses. The absence of the 
furin cleavage site indicates the absence of enhanced efficiency of host cell entry observed with SARS-CoV-250. 
However, RhGB01 does retain a similar motif responsible for cleavage in the S2’ region by host transmembrane 
serine protease 2, also required for spike protein proteolytic priming for ACE2  attachment47. SARS-CoV-2 
variants with a functional ORF8 are associated with greater pathogenicity, thought to be due to downregulation 
of major histocompatibility complex class 1 (MHC 1), and thus a reduction in antigen presentation to  CD8+ T 
Figure 3.  A schematic representation of the entire S protein with the RBM and cleavage sites highlighted 
and compared between RhGB01, Pangolin and Bat derived related viruses, SARS-CoV and SARS-CoV-2 and 
percentage identity values for the RBD and RBM regions. Amino acids are coloured according to the Taylor 
colour scheme. (A) RBM comparison demonstrates higher percentages of homology within sarbecoviruses from 
other zoonotic hosts. The RBM of MERS-HCoV-EMC-2012, subgenus Merbecovirus, demonstrates little amino 
acid homology to RBM from the Sarbecovirus subgenus. The furin cleavage site (S1/S2) is only present in SARS-
CoV-2, distinct from the TMPRSS2 cleavage motif (S2′), which is more conserved within the sarbecoviruses. (B) 
Percentage identity scores for the RBM and RBD to SARS-CoV and SARS-CoV-2. RaTG13 and PCoV represent 
the most closely SARSr-CoV-2 virus from zoonotic hosts.
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lymphocytes which facilitates prolonged  infection51,52. The absence of ORF8 from the genome of RhGB01 sug-
gests that this virus lacks these immune evasion properties.
It has been postulated that both SARS-CoV and SARS-CoV-2 evolved through mutation, possibly involving 
homologous recombination, during passage through at least one intermediate host; probably civets (viverrids) 
or mustelids for SARS-CoV53,54 and possibly a species of pangolin for SARS-CoV-249. In this way, the progenitor 
virus from the natural host (a species of horseshoe bat) gained genetic adaptations to allow successful infection 
of, and transmission between, human beings. Where there is opportunity for homologous recombination of 
sarbecoviruses through co-infection, there is the possibility of novel zoonotic emergence. Thus, co-infection of 
horseshoe bats with their natural suites of coronaviruses and with SARS-CoV-2 could lead to the development 
of novel zoonotic emergence. While there is a need to increase surveillance for coronaviruses in horseshoe bats 
across their range, and also in other bat species, especially those syntopic with, or closely related to, horseshoe 
bats (e.g. the Old World leaf-nosed bats, family Hipposideridae), it is also important that steps are taken to 
minimise opportunities of virus transmission between novel hosts.
In Europe, unlike in Asia, direct contact between people and bats most commonly occurs when the animals 
are captured by bat researchers or when sick animals are taken in by bat rescuers and wildlife rehabilitation 
centres. While the risk of reverse spill over of SARS-CoV-2 from researchers to bats and onward spread within 
bat populations has been shown to be medium to  high55, it is the caring of sick or injured bats, in particular, that 
provides most opportunity for long-term close contact and virus transfer in either direction. Although the IUCN 
Bat Specialist Group has produced guidelines to minimise this  risk56, the degree to which these are known or 
followed is unclear. Our findings highlight that the natural distribution of sarbecoviruses and opportunities for 
recombination through intermediate host co-infection are underestimated. Preventing transmission of SARS-
CoV-2 to horseshoe bats, with the risk this presents of further mutation, is of particular significance with the 
current roll out of a global mass vaccination campaign against this virus.
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